Stock info Ascendis Pharma A/S | Filter  Basic-Info

Stock: Ascendis Pharma A/S (US broad)

Last Price 134.43 Max Price 157.54
Min Price 113.81 1 Year return 10.07
Sector Health Care Subsector Biotechnology

Loading...

Contact info:Country: USA

Sector Review Ascendis Pharma A/S

Loading...
Year Turnover Total sector Market share
2019 13 141,925 0.01 %
2020 7 170,231 0.00 %
2021 8 252,886 0.00 %
2022 51 238,496 0.02 %
2023 0 0 0.00 %

Advice Ascendis Pharma A/S

No Records Found



News Ascendis Pharma A/S

No Records Found

Annual reports Ascendis Pharma A/S

No Records Found

Profile Ascendis Pharma A/S

No Records Found

Results Ascendis Pharma A/S

Results
2015
2016
2017
2018
2019
2020
Revenue
8
5
2
11
13
7
Costs
41
73
125
141
231
426
Profit
-33
-69
-124
-130
-218
-419
Margin of profit
-405.42
-1486.12
-8098.04
-1229.68
-1629.45
-6028.20
ROI
-27.36
-38.79
-66.18
-46.46
-36.51
-49.95

Balance Ascendis Pharma A/S

Balance
2015
2016
2017
2018
2019
2020
Equity
120
177
187
280
597
839
Debt
11
13
24
39
80
141
Total assets
132
190
211
319
677
980
Solvency
91.32
92.92
88.73
87.80
88.23
85.60
Cash
120
180
195
278
592
719
Cashflow
-43
-60
-95
-139
-176
-272
Employees
0
0
0
0
0
Revenue per employee
0.0
0.0
0.0
0.0
0.0
Cashflow / Debt
-3.80
-4.47
-4.00
-3.57
-2.21
-1.92

Details Ascendis Pharma A/S

Details
2016
2017
2018
2019
2020
Price
18.32
20.24
40.06
62.65
139.12
Eps
-2.58
-3.68
-3.17
-4.69
-8.28
Price/earnings-ratio
-7.10
-5.50
-12.64
-13.36
-16.24
Dividend
0.0
0.0
0.0
0.0
Dividend %
0.00 %
0.00 %
0.00 %
0.00 %
Payout %
0.0
0.0
0.0
0.0
Book value
5.45
5.06
6.65
12.44
15.60
Market to book
0.30
0.25
0.17
0.20
0.12
Cashflow per stock
-1.86
-2.57
-3.29
-3.67
-5.05
Stocks
32
37
42
48
54
Market Cap
593.95
748.56
1.687.94
3.006.31
7.225.67

Dividend Ascendis Pharma A/S

Price info Ascendis Pharma A/S

Date
Price
09 Jan 2025
134.43
17 Dec 2024
136.60
10 Dec 2024
132.42
06 Dec 2024
132.07
03 Dec 2024
133.51
29 Nov 2024
136.32
27 Nov 2024
134.60
13 Nov 2024
127.67
08 Nov 2024
126.55
05 Nov 2024
125.77
31 Oct 2024
122.80
29 Oct 2024
129.44
23 Oct 2024
129.07
19 Oct 2024
129.90
16 Oct 2024
127.30
14 Oct 2024
128.87
05 Oct 2024
142.67
02 Oct 2024
146.60
27 Sep 2024
147.36
20 Sep 2024
153.43
17 Sep 2024
139.57
13 Sep 2024
113.81
28 Aug 2024
138.79
26 Aug 2024
139.68
23 Aug 2024
139.39
11 Aug 2024
126.97
07 Aug 2024
125.51
05 Aug 2024
132.26
01 Aug 2024
133.50
30 Jul 2024
134.25
Overig aandelennieuws
Ascendis Pharma A/S Announces Upcoming Investor Presentation in November
Ascendis Pharma A/S Announces Third Quarter 2019 Financial Results and Business Update Conference Call on November 18
Ascendis Pharma A/S Receives Orphan Designation for TransCon™ hGH for the Treatment of Pediatric Growth Hormone Deficiency in Europe
Ascendis Pharma A/S Announces Presentations on Achondroplasia and TransCon™ CNP at International Skeletal Dysplasia Society Meeting
Ascendis Pharma A/S Announces Three Investor Presentations in September
Ascendis Pharma A/S Reports Second Quarter 2019 Financial Results
Ascendis Pharma A/S Announces Second Quarter 2019 Financial Results and Business Update Conference Call on August 28
Logoanalist
Returns European stocks
Crypto currencies information
About us Network Partners
Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos Analist.nlLinksISIN
  • Glossary
    		• MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-xBats
    ©2025 ValueSpectrum. All Rights Reserved
    Developed and maintained by  Velainn logo